Management of acute atrial fibrillation

EBM Guidelines
Aug 19, 2022 • Latest change Mar 21, 2024
Pekka Raatikainen

Table of contents

Extract

  • In the treatment of acute atrial fibrillation (AF), the choice between rhythm control and rate control as the treatment approach is made on an individual basis (see Treatment approach for atrial fibrillation: rate control or rhythm control?2). At the same it must be ensured that anticoagulation treatment is implemented according to recommendations.
  • As a common rule in frequently recurring AF, it is worthwhile to omit cardioversion and to concentrate on rate control if it is not possible to intensify preventive therapy.

Read full article of Management of acute atrial fibrillation

Search terms

AF, Adrenergic beta-antagonists, Amiodarone, Anti-arrhythmia agents, Anticoagulants, Anticoagulation, Atrial fibrillation, Atrial fibrillation, acute, Atrioventricular conduction, Atrioventricular node, Beta-blockers, Calcium channel blockers, Cardiac pacing, artificial, Cardiology, Cardioversion, Cardioversion, pharmacological, Digoxin, Diltiazem, Electric countershock, Flecainide, Heart rate, Hemodynamic processes, I48*, Ibutilide, Internal medicine, Pacemaker, Propafenone, Rate control, TOE, Transoesophageal echocardiography, Ventricular rate, Verapamil, WPW, Wolff-Parkinson-White syndrome, vernakalant